In this video, Marcus Wilson, MD, President, HealthCore, talks about the important relationship between electronic medical record data and claims data.
In this video, Marcus Wilson, MD, President, HealthCore, talks about the important relationship between electronic medical record data and claims data.
"Claims data has its unique strengths and its inherent weaknesses. Electronic medical record data has strengths and weaknesses as well and is actually very different than claims data. So, when you combine those data together, you are actually pulling on the strings of each and also addressing the weaknesses of the [one data source] with the strengths of the other."
This video was taken on Thursday, October 4, 2012, at the Academy of Managed Care Pharmacy's 2012 Educational Conference in Cincinnati, OH.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More